RNA interference screening identifies a novel role for autocrine fibroblast growth factor signaling in neuroblastoma chemoresistance

A phase I safety study of enzastaurin plus bortezomib in the treatment of relapsed or refractory multiple myeloma

(2011) Irene M. Ghobrial et al.   AMERICAN JOURNAL OF HEMATOLOGY

Synergistic Activity of Fenretinide and the Bcl-2 Family Protein Inhibitor ABT-737 against Human Neuroblastoma

(2011) H. Fang et al.   CLINICAL CANCER RESEARCH

Oncogene Mutation Profiling of Pediatric Solid Tumors Reveals Significant Subsets of Embryonal Rhabdomyosarcoma and Neuroblastoma with Mutated Genes in Growth Signaling Pathways

(2011) N. Shukla et al.   CLINICAL CANCER RESEARCH

Synergistic Effect between Erlotinib and MEK Inhibitors in KRAS Wild-Type Human Pancreatic Cancer Cells

(2011) C. H. Diep et al.   CLINICAL CANCER RESEARCH

Breast cancer genome-wide association studies: there is strength in numbers

(2011) D Fanale et al.   ONCOGENE

miRNA Expression Profiling of the Murine TH-MYCN Neuroblastoma Model Reveals Similarities with Human Tumors and Identifies Novel Candidate MiRNAs

(2011) Marta Terrile et al.   PLoS One

RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma

(2011) K. A. Cole et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Inhibition of FGFR2 and FGFR1 increases cisplatin sensitivity in ovarian cancer

(2010) Claire Cole et al.   CANCER BIOLOGY & THERAPY

Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method

(2010) T.-C. Chou   CANCER RESEARCH

NF1 Is a Tumor Suppressor in Neuroblastoma that Determines Retinoic Acid Response and Disease Outcome

(2010) Michael Hölzel et al.   CELL

Recent Advances in Neuroblastoma

(2010) John M. Maris   NEW ENGLAND JOURNAL OF MEDICINE

An ERK-dependent pathway to Noxa expression regulates apoptosis by platinum-based chemotherapeutic drugs

(2010) C Sheridan et al.   ONCOGENE

Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets

(2010) N Turner et al.   ONCOGENE

Stabilization of N-Myc Is a Critical Function of Aurora A in Human Neuroblastoma

(2009) Tobias Otto et al.   CANCER CELL

BH3 response profiles from neuroblastoma mitochondria predict activity of small molecule Bcl-2 family antagonists

(2009) K C Goldsmith et al.   CELL DEATH AND DIFFERENTIATION

Bcl-2 Blocks Cisplatin-Induced Apoptosis and Predicts Poor Outcome Following Chemoradiation Treatment in Advanced Oropharyngeal Squamous Cell Carcinoma

(2009) W. A. Michaud et al.   CLINICAL CANCER RESEARCH

FGFR2 as a molecular target in endometrial cancer

(2009) Sara A Byron et al.   Future Oncology

Identification of CDK10 as an Important Determinant of Resistance to Endocrine Therapy for Breast Cancer

(2008) Elizabeth Iorns et al.   CANCER CELL

Cathepsin D protects human neuroblastoma cells from doxorubicin-induced cell death

(2008) Vitalia Sagulenko et al.   CARCINOGENESIS

Targeting the Phosphoinositide 3-Kinase Isoform p110  Impairs Growth and Survival in Neuroblastoma Cells

(2008) D. Boller et al.   CLINICAL CANCER RESEARCH

Bradykinin-induced IL-6 expression through bradykinin B2 receptor, phospholipase C, protein kinase Cδ and NF-κB pathway in human synovial fibroblasts

(2008) Cheng-Hung Lee et al.   MOLECULAR IMMUNOLOGY